Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 AUD | -2.99% | -2.99% | +30.00% |
05-06 | Firebrick Pharma Appoints Auditor | MT |
04-17 | Firebrick Pharma's Nasodine Nasal Spray Enters US Market | MT |
Sales 2022 | 1.08M 724K 985K | Sales 2023 | 22.55K 15.06K 20.51K | Capitalization | 27.32M 18.25M 24.84M |
---|---|---|---|---|---|
Net income 2022 | -3M -2M -2.73M | Net income 2023 | -6M -4.01M -5.46M | EV / Sales 2022 | 34.7 x |
Net cash position 2022 | 7.15M 4.77M 6.5M | Net cash position 2023 | 2.35M 1.57M 2.14M | EV / Sales 2023 | 1,107 x |
P/E ratio 2022 |
-8.13
x | P/E ratio 2023 |
-3.88
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.97% |
1 day | -2.99% | ||
1 week | -2.99% | ||
Current month | +3.17% | ||
1 month | +22.64% | ||
3 months | +22.64% | ||
6 months | -5.80% | ||
Current year | +30.00% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Goodall
FOU | Founder | - | 12-04-11 |
Chief Executive Officer | 70 | 12-04-11 | |
Kavi Bekarma
DFI | Director of Finance/CFO | - | 23-01-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis Gardner
BRD | Director/Board Member | 73 | 20-11-12 |
Richard Treagus
BRD | Director/Board Member | 58 | 22-05-31 |
Chief Executive Officer | 70 | 12-04-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 0.065 | -2.99% | 15,300 |
24-05-15 | 0.067 | 0.00% | 37,898 |
24-05-14 | 0.067 | -1.47% | 111,544 |
24-05-13 | 0.068 | +3.03% | 19,430 |
24-05-10 | 0.066 | 0.00% | 114 |
Delayed Quote Australian S.E., May 16, 2024 at 01:49 am
More quotes1st Jan change | Capi. | |
---|---|---|
+30.00% | 8.03M | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- FRE Stock